Protocol Library
Each card lists peptide research notes — vial size, example research dose range, reconstitution example, frequency example, cycle length example, and risk level. All entries are educational. Not medical advice.
Cerebrolysin
moderate riskStudied for its role in neurotrophic signaling, cognitive research and post-ischemic neurological research models.
- Vial
- 5 ml ampoule
- Dose
- Published clinical research commonly cites 5–30 ml per research day intravenous-equivalent ranges.
- Freq
- Daily research dosing across multi-week courses in published studies.
- Cycle
- Common research courses: 10–30 days.
Epithalon
low riskResearched in pineal and telomerase contexts.
- Vial
- 10 mg
- Dose
- 5–10 mg daily (research literature)
- Freq
- Once daily (research example)
- Cycle
- 10–20 days (research example)
FOXO4-DRI
high riskInvestigated for disruption of FOXO4–p53 interaction in senescent cells.
- Vial
- 5 mg lyophilized vial
- Dose
- Educational research dose example only; preclinical literature.
- Freq
- Pulsed protocols in research designs.
- Cycle
- Short pulsed cycles.
GHK-Cu
low riskResearched in dermal repair, hair follicle, and anti-aging contexts.
- Vial
- 50 mg
- Dose
- 1–2 mg per use (research literature)
- Freq
- Topical or subq (research example)
- Cycle
- 4–8 weeks (research example)
Glutathione
low riskResearched as a master antioxidant in oxidative stress contexts.
- Vial
- 600 mg
- Dose
- 200–600 mg per use (research literature)
- Freq
- 1–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
Livagen
low riskInvestigated in research literature for chromatin decondensation and lymphocyte activity.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
MOTS-c
low riskResearched in mitochondrial and metabolic regulation contexts.
- Vial
- 10 mg
- Dose
- 5–10 mg weekly (research literature)
- Freq
- 2–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
NAD+
moderate riskResearched in NAD+ metabolism and cellular energy contexts.
- Vial
- 500 mg
- Dose
- 100–500 mg per use (research literature)
- Freq
- 1–3x weekly (research example)
- Cycle
- 4–8 weeks (research example)
Pinealon
low riskInvestigated for neuroprotective signaling in preclinical research literature.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
PNC-27
high riskInvestigated for selective membrane interaction with HDM-2-expressing cells in preclinical research.
- Vial
- 10 mg lyophilized vial
- Dose
- Educational research dose example only; preclinical literature.
- Freq
- Protocol-dependent.
- Cycle
- Short pulsed research cycles.
Prostamax
low riskInvestigated in Khavinson-school research for organ-specific peptide signaling.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
SS-31 (Elamipretide)
moderate riskResearched in mitochondrial cardiolipin and energy production contexts.
- Vial
- 10 mg
- Dose
- 1–5 mg daily (research literature)
- Freq
- Once daily (research example)
- Cycle
- 4–8 weeks (research example)
Testagen
low riskInvestigated for thymic-related signaling in Khavinson-school research literature.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
Thymosin Alpha-1
low riskResearched in T-cell and immune support contexts.
- Vial
- 5 mg
- Dose
- 1.6 mg twice weekly (research literature)
- Freq
- 2x weekly (research example)
- Cycle
- 4–8 weeks (research example)
Vesugen
low riskInvestigated for vascular endothelial signaling in research literature.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
Vilon
low riskInvestigated for immunomodulatory and chromatin-related signaling research.
- Vial
- 20 mg lyophilized vial
- Dose
- Educational research dose example only.
- Freq
- Daily in short research cycles.
- Cycle
- 10–20 day educational example.
Looking for a research supplier?
Enhanced Performance is a separate research supply platform. Visiting or purchasing is optional and not required to use PepToolbox.
Disclosure: Enhanced Performance is a separate platform connected to the owner of this website. Purchasing is optional and not required to use this tool.